Targeting TWEAK/Fn14 pathway: Implications for stem cell regulation and advancements in skin disease therapies
Ahmad Taha Khalaf1, Xiaoming Liu2
1Medical College, Anhui University of Science and Technology (AUST), Huainan 232001, China.
Abstract:
Tumor necrosis factor-like weak apoptosis-inducing factor (TWEAK), a member of the TNF superfamily, plays a critical role in regulating numerous cellular processes, including proliferation, differentiation, and migration, through its sole receptor, fibroblast growth factor-inducible 14 (Fn14). This signaling pathway has broad implications in normal physiology and the pathogenesis of various diseases. In skin disorders, TWEAK/Fn14 signaling is implicated in fibroproliferation, angiogenesis, and inflammation. It is upregulated in the serum and urine of patients with conditions like lupus erythematosus, psoriasis, and skin tumors. On the one hand, moderate activation of this pathway promotes skin wound healing; on the other hand, prolonged or excessive activation may lead to pathological tissue damage. Beyond skin diseases, TWEAK/Fn14 signaling also influences the behavior of various stem cells, including liver, neural, and mesenchymal stem cells, modulating their proliferation and differentiation during tissue repair and regeneration. Given its diverse biological roles, this pathway holds potential as both a diagnostic biomarker for early disease detection and a therapeutic target for treating a range of conditions. This review examines the dual roles of TWEAK/Fn14 signaling in both skin disease pathogenesis and stem cell regulation, highlighting its potential to advance research in disease mechanisms, stem cell therapy, and tissue engineering.
Insights
Tumor necrosis factor-like weak apoptosis-inducing factor (TWEAK) and its receptor Fn14 are crucial in cell regulation and disease. This pathway
Area of Science:
- Immunology
- Cell Biology
- Dermatology
Background:
- Tumor necrosis factor-like weak apoptosis-inducing factor (TWEAK) is a TNF superfamily member that signals through fibroblast growth factor-inducible 14 (Fn14).
- This TWEAK/Fn14 pathway regulates critical cellular functions like proliferation, differentiation, and migration.
- Dysregulation of TWEAK/Fn14 signaling is implicated in various diseases, including skin disorders and stem cell behavior.
Purpose of the Study:
- To review the dual roles of TWEAK/Fn14 signaling in skin disease pathogenesis.
- To examine the influence of TWEAK/Fn14 signaling on stem cell regulation.
- To highlight the potential of TWEAK/Fn14 as a diagnostic biomarker and therapeutic target.
Main Methods:
- Literature review of studies on TWEAK/Fn14 signaling.
- Analysis of TWEAK/Fn14 involvement in skin disorders (e.g., lupus, psoriasis).
- Investigation of TWEAK/Fn14 effects on stem cell behavior (liver, neural, mesenchymal).
Main Results:
- TWEAK/Fn14 signaling is upregulated in skin diseases, contributing to fibroproliferation, angiogenesis, and inflammation.
- Moderate TWEAK/Fn14 activation aids wound healing, while excessive activation causes pathological damage.
- TWEAK/Fn14 influences stem cell proliferation and differentiation, impacting tissue repair and regeneration.
Conclusions:
- The TWEAK/Fn14 pathway exhibits a dual role, promoting healing at moderate levels but causing damage when overactivated.
- TWEAK/Fn14 signaling is a key factor in skin disease development and stem cell modulation.
- Targeting the TWEAK/Fn14 pathway offers potential for early disease detection and novel therapeutic strategies in regenerative medicine and tissue engineering.
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Clinical Applications of Epidermal Stem Cells
iPS Cell Differentiation
Stem Cell Niche
Tissue Renewal without Stem Cells
However, failure of such a system...


